Cargando…

Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer

BACKGROUND: In China, the middle esophageal squamous cell cancer is the most common tumor type, and Mckeown esophagectomy (ME) is preferably adopted by thoracic surgeon. But, the surgical trauma of ME is great. Thoracolaparoscopic esophagectomy (TE) was developed to decrease the operative stress; ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hai-Tao, Wang, Fei, Shen, Liang, Xia, Chun-Qiu, Lu, Chen-Xi, Zhong, Chong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635614/
https://www.ncbi.nlm.nih.gov/pubmed/26542373
http://dx.doi.org/10.1186/s12957-015-0727-y
_version_ 1782399533029785600
author Huang, Hai-Tao
Wang, Fei
Shen, Liang
Xia, Chun-Qiu
Lu, Chen-Xi
Zhong, Chong-Jun
author_facet Huang, Hai-Tao
Wang, Fei
Shen, Liang
Xia, Chun-Qiu
Lu, Chen-Xi
Zhong, Chong-Jun
author_sort Huang, Hai-Tao
collection PubMed
description BACKGROUND: In China, the middle esophageal squamous cell cancer is the most common tumor type, and Mckeown esophagectomy (ME) is preferably adopted by thoracic surgeon. But, the surgical trauma of ME is great. Thoracolaparoscopic esophagectomy (TE) was developed to decrease the operative stress; however, the safety and efficacy were not defined. In this study, clinical outcomes were compared between patients who received ME and TE. METHODS: The data of 113 patients who suffered from middle-thoracic esophageal cancer during the same period were collected. Sixty-two patients received ME (ME group), and 51 patients received TE (TE group). Patients’ demographics and short-term clinicopathologic outcomes were comparable between the two groups. Survival rate was estimated using the Kaplan–Meier method, and comparisons between groups were performed with log–rank test. RESULTS: Patients in TE group had lower body mass index (BMI). Preoperative tumor stage in TE group was much earlier. Both overall and thoracic operation time were longer in TE group. The blood loss during operation and postoperative day (POD) 1 was less in TE group, which contributed to the less blood transfusion. In TE group, postoperative incidence of pulmonary complications and atrial fibrillation (p = 0.035 and p = 0.033) was lower; the inflammatory response and incision pain were significantly alleviated; the ICU and in-hospital stay was shorter as well because of less surgical trauma. No statistically significant difference was found between two groups in terms of overall survival or disease-free survival. CONCLUSIONS: The efficacy and safety of TE were supported by the selected patients in this cohort study. Although it is lack of randomness in this research, some advantages of TE were gratifying such as lower postoperative complications and similar survival with ME. A multicenter prospective randomized study is now required.
format Online
Article
Text
id pubmed-4635614
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46356142015-11-07 Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer Huang, Hai-Tao Wang, Fei Shen, Liang Xia, Chun-Qiu Lu, Chen-Xi Zhong, Chong-Jun World J Surg Oncol Research BACKGROUND: In China, the middle esophageal squamous cell cancer is the most common tumor type, and Mckeown esophagectomy (ME) is preferably adopted by thoracic surgeon. But, the surgical trauma of ME is great. Thoracolaparoscopic esophagectomy (TE) was developed to decrease the operative stress; however, the safety and efficacy were not defined. In this study, clinical outcomes were compared between patients who received ME and TE. METHODS: The data of 113 patients who suffered from middle-thoracic esophageal cancer during the same period were collected. Sixty-two patients received ME (ME group), and 51 patients received TE (TE group). Patients’ demographics and short-term clinicopathologic outcomes were comparable between the two groups. Survival rate was estimated using the Kaplan–Meier method, and comparisons between groups were performed with log–rank test. RESULTS: Patients in TE group had lower body mass index (BMI). Preoperative tumor stage in TE group was much earlier. Both overall and thoracic operation time were longer in TE group. The blood loss during operation and postoperative day (POD) 1 was less in TE group, which contributed to the less blood transfusion. In TE group, postoperative incidence of pulmonary complications and atrial fibrillation (p = 0.035 and p = 0.033) was lower; the inflammatory response and incision pain were significantly alleviated; the ICU and in-hospital stay was shorter as well because of less surgical trauma. No statistically significant difference was found between two groups in terms of overall survival or disease-free survival. CONCLUSIONS: The efficacy and safety of TE were supported by the selected patients in this cohort study. Although it is lack of randomness in this research, some advantages of TE were gratifying such as lower postoperative complications and similar survival with ME. A multicenter prospective randomized study is now required. BioMed Central 2015-11-05 /pmc/articles/PMC4635614/ /pubmed/26542373 http://dx.doi.org/10.1186/s12957-015-0727-y Text en © Huang et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Huang, Hai-Tao
Wang, Fei
Shen, Liang
Xia, Chun-Qiu
Lu, Chen-Xi
Zhong, Chong-Jun
Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
title Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
title_full Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
title_fullStr Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
title_full_unstemmed Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
title_short Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer
title_sort comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with mckeown esophagectomy for middle esophageal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635614/
https://www.ncbi.nlm.nih.gov/pubmed/26542373
http://dx.doi.org/10.1186/s12957-015-0727-y
work_keys_str_mv AT huanghaitao comparisonofthoracolaparoscopicesophagectomywithcervicalanastomosiswithmckeownesophagectomyformiddleesophagealcancer
AT wangfei comparisonofthoracolaparoscopicesophagectomywithcervicalanastomosiswithmckeownesophagectomyformiddleesophagealcancer
AT shenliang comparisonofthoracolaparoscopicesophagectomywithcervicalanastomosiswithmckeownesophagectomyformiddleesophagealcancer
AT xiachunqiu comparisonofthoracolaparoscopicesophagectomywithcervicalanastomosiswithmckeownesophagectomyformiddleesophagealcancer
AT luchenxi comparisonofthoracolaparoscopicesophagectomywithcervicalanastomosiswithmckeownesophagectomyformiddleesophagealcancer
AT zhongchongjun comparisonofthoracolaparoscopicesophagectomywithcervicalanastomosiswithmckeownesophagectomyformiddleesophagealcancer